SING GEORGE L received a stock award from REGENERON PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/6/2026ACC: 0001225471-26-000002
Director
Since Jan 2019
+2.12K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
2.12K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+155.00
Price / share
—
Trade value
—
% of position
0.5%
1/2/2026
30.85K→31.01K
Total
Net shares
+155.00
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2026 | A · Award | +155.00 | — | — | 0.5% | 30.85K | 31.01K |
| Total | +155.00 | $0.00 | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
1.96K shares
Shares
+1.96K
Strike price
772.76
Held after
1.96K
Exercisable
—
1/2/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock1.96K shares | 1/2/2026 | A · Award | +1.96K | 772.76 | — | 1.96K |
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned750.00
Common Stock
IndirectShares owned400.00
Common Stock
IndirectShares owned1K
Total
2.15K indirect2.15K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 750.00 | Indirect |
| Common Stock | 400.00 | Indirect |
| Common Stock | 1K | Indirect |
| Total | 2.15K | 2.15K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported